Clinical Trials
143 trialsIdentification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
St. Jude Children's Research Hospital
BLOOD-dose
Rigshospitalet, Denmark
Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy
M.D. Anderson Cancer Center
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
Konkuk University Medical Center
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
BDH-WM02
Institute of Hematology & Blood Diseases Hospital, China
BDH-WM01
Institute of Hematology & Blood Diseases Hospital, China
BDH-WM03
Institute of Hematology & Blood Diseases Hospital, China
BDH-MCL01
Institute of Hematology & Blood Diseases Hospital, China
PPPOCUS
University of California, Irvine
Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma
Beijing Tongren Hospital
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Gadjah Mada University
Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
Massachusetts General Hospital
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
The First Affiliated Hospital of Soochow University
ZSDT for the Treatment of R/R Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Clinical Trial
Zhengzhou University
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
Gadjah Mada University
HEMATOVAC
Poitiers University Hospital
Glofitamab
Zhengzhou University
Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL
Institute of Hematology & Blood Diseases Hospital, China
Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
Ain Shams University
Hepatoprotective Measures for Children at High Risk of NAFLD
Ain Shams University
Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting
Vanderbilt-Ingram Cancer Center
BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma
Dalian Medical University
Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia
Tongji Hospital
Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
Ruijin Hospital
axi-cel
Zhengzhou University
Antimicrobial Revision in Persistent Febrile Neutropenia
Wake Forest University Health Sciences
Clinical Study of OR for Second-line Treatment of Refractory MZL
Ningbo No. 1 Hospital
BRRPJS
Peking Union Medical College Hospital
RATAPED
Ramsay Générale de Santé
EuroNetLP1
Martin-Luther-Universität Halle-Wittenberg
RONIN
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
LymBIO
IRCCS San Raffaele
Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells
Chongqing University Cancer Hospital
A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma
Changhai Hospital
Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma
University of Guadalajara
Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma
Chongqing University Cancer Hospital
German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Goethe University
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)
Goethe University
Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia
Goethe University
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)
Goethe University
Plerixafor for Poorly Mobilized Lymphoma
Peking University
Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures
CAMC Health System
Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO
University of Texas Southwestern Medical Center
SCCCG-R-ALL
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Reduced Chemotherapy in Low Risk DLBCL
Ruijin Hospital
N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric Leukemia
Dr Cipto Mangunkusumo General Hospital
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults
Goethe University
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)
Goethe University